Log In
Print this Print this

KD019, XL647

  Manage Alerts
Collapse Summary General Information
Company Symphony Evolution Inc.
DescriptionSpectrum selective inhibitor of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and HER2/neu/ErbB2 receptor
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu) ; Vascular endothelial growth factor (VEGF) receptor
Mechanism of ActionKinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today